Tapentadol is partially metabolized by the hepatic enzymes CYP2C9, CYP2C19, and CYP2D6 so it innately has interactions with medicine that enhance or repress the exercise/expression of one or more of those enzymes, and with substrates of those enzymes (as a result of Competitors for that enzyme); some enzyme mediators/substrates have https://daveyp898ohy0.life-wiki.com/user